IMMUNOINSIGHTS
Live / Registered — Registered (as of 08 Nov 2022)
What this means for you
Registered since 08 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90532440
- Registration number
- 6896312
- Mark type
- Stylized text
- Filed
- 17 Feb 2021
- Published for opposition
- 26 Oct 2021
- Registered
- 08 Nov 2022
- Attorney of record
- Stephen D. Wilson, Esq.
Goods and services
- Class 042 — Scientific and technological services: Scientific research services for medical purposes; detection of biomarkers in mammalian and human samples for scientific research purposes; detection of antibodies in human and mammalian samples for scientific research purposes; all of the above excluding services related to prosthetics and artificial limbs
- Class 044 — Medical, beauty and agricultural services: Medical services; information and advisory services relating to medical testing kits; medical diagnostic monitoring services; all of the above excluding services related to prosthetics and artificial limbs
Owner
- Oncimmune Germany GmbH, Dortmund, DE
- Oncimmune Germany GmbH, Dortmund, DE
- Oncimmune Germany GmbH, Dortmund, DE
Prosecution history
- 06 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Aug 2022 — USE AMENDMENT FILED
- 01 Sept 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Aug 2022 — TEAS STATEMENT OF USE RECEIVED
- 23 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED